Form 8-K - Current report:
SEC Accession No. 0001171843-25-003881
Filing Date
2025-06-13
Accepted
2025-06-13 16:02:09
Documents
12
Period of Report
2025-06-12
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_061325.htm   iXBRL 8-K 27697
  Complete submission text file 0001171843-25-003881.txt   193338

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE crvs-20250612.xsd EX-101.SCH 3026
3 XBRL LABEL FILE crvs-20250612_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE crvs-20250612_pre.xml EX-101.PRE 22366
14 EXTRACTED XBRL INSTANCE DOCUMENT f8k_061325_htm.xml XML 3707
Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
Business Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Filer) CIK: 0001626971 (see all company filings)

EIN.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37719 | Film No.: 251046335
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)